Fasting Plasma Glucose as a Primary Screening Test for the Diagnosis of Gestational Diabetes mellitus

Introduction

Gestational diabetes mellitus (GDM) is one of the most typically encountered endocrine issues in pregnancy. About one in six women globally and one in four women in Southeast Asia has been suffering from some form of hyperglycemia in pregnancy (HIP), and GDM contributes about 80% of cases of HIP.¹ It is associated with many complications for both mother and offspring reported from many well-established studies from different parts of the world.^2-6 Screening for GDM is essential as a high prevalence of GDM is observed in Southeast Asia. Although screening for GDM with an oral glucose tolerance test is a gold standard and ideal procedure, but it is inconvenient, unpleasant, time-consuming, and unsuitable for large-scale screening. Furthermore, oral glucose load is not well accepted by many patients. One study reported that nearly half of the pregnant women were extremely bothered with having to drink the glucose solution.⁷Conversely, fasting plasma glucose (FPG) is inexpensive, reproducible, and suitable for a screening test. In the Hyperglycemia and pregnancy outcome (HAPO) study, 51% of GDM was diagnosed by an FPG > 5.1 mmol/L.⁸In China, Due to complexity of Chinese vast geography and population, they have adapted a two steps strategy for GDM screening with FPG. They selectively do OGTT in pregnancy if FPG value is found between 4.4 to 5.0mmol/L. This simplicity of test procedure ensures universal screening of GDM in low resource setting. ⁹In one study from South Africa reported, FPG of ≥5.1 mmol/L identified 87.8% of GDM patients and the sensitivity and specificity of FPG ≥4.5 mmol/L were 98% and 80%, respectively.¹⁰Our study aimed to see the sensitivity and specificity of FPG with different cut-off values as a screening test for GDM in different trimesters.

Materials & method

Result

Our study populations were mainly from housewife occupational category (69%) and majority of them was multigravida (59%). About half of the study populations (49.1%) were from second trimester and only 16% of them from first trimester (Table 1). Based on WHO 2013 criteria, 30.5% of the study populations had AGT, of which GDM were 26.4% and DIP were 4.1% as depicted in figure 1. The sensitivity of FPG as a screening test for GDM compared to three samples 75g OGTT was 47.5% among the study subjects, which was very low but it’s specificity, positive predictive value, negative predictive value were seemed to be good (99.73%, 98.73% and 81.21% respectively). However, changing the cut off value of FPG from 5.1mmol to 4.7mmo/L and 4.5mmol/L significantly increased the sensitivity to 64.8% and 73.3% respectively (Figure 2). Selecting the study population between 24-28 weeks of gestation mildly increased the diagnostic sensitivity and specificity of FPG and a threshold of 4.5mmol/L could identify 75% of GDM subjects with specificity 76.8% (Figure 3). Trimester specific analysis of efficacy of FPG revealed the FPG has the highest sensitivity for diagnosis of GDM in first trimester (80%) whatever the cut-off value used for diagnosis, but its sensitivity progressively declined in subsequent trimesters (Table 2). Among different cut off value of FPG, 4.5mmol/L had the highest sensitivity in all three trimester for diagnosis of GDM (Table 2). Pearson correlation revealed FPG had positive and significant correlation with maternal age and BMI; however it was negatively correlated with gestational weeks (Table 3).

• Download figure
• Open in new tab

Figure 1:

Glycemic status among the study subjectsaccording to WHO 2013 criteria.

(NGT= Normal Glucose Tolerance, DIP= Diabetes in Pregnancy, GDM= Gestational Diabetes mellitus)

• Download figure
• Open in new tab

Figure 2:

Diagnostic efficacy of Fasting Plasma Glucose in study subjects of all trimester (n=542) with different cut off value (5.1, 4.7 and 4.5 mmol/L)

• Download figure
• Open in new tab

Figure 3:

Diagnostic efficacy of Fasting Plasma Glucose in pregnant women with gestational age 24-28 weeks (n=122) with different cut off value (5.1, 4.7 and 4.5 mmol/L)

Figure-4 shows the receiver operating characteristic (ROC) curve showing the performance of FPG in diagnosing AGT of pregnancy (AUC 0.80; 95% CI: 0.76-0.85; p<0.001). The Youden index was 0.56 at the FPG cut-off 4.59 mmol/L with a sensitivity of 70% and specificity 81%.

• Download figure
• Open in new tab

Figure-4:

The Receiver Operating Characteristic (ROC) curve showing the performance of FPG in diagnosing AGT in pregnancy among the study subjects (N=542)

FPG: fasting plasma glucose, AGT: abnormal glucose tolerance (includes gestational diabetes mellitus and diabetes in pregnancy)

Discussion

It is well established from pregnancy outcome based study that the OGTT is a gold standard for diagnosis of GDM.¹¹ However many pregnant women feel distressed during oral glucose load for OGTT.⁷ The use of FPG as an screening test to avoid OGTT was studied by many researcher in different country with very positive result.^10,12-16 In our study, FPG could identify only 47.5% pregnant women with GDM with the same cut off value used in WHO 2013 criteria and international association of diabetes in pregnancy study group (IADPSG) criteria, which is a little bit similar to a study done by Agarwal MM et al. ¹⁷ However, changing the cut off value of FPG from 5.1mmol to 4.5mmol/L significantly increased the sensitivity to 73.3% and specificity 73.2%. A study done among the Mexican population reported that the FPG threshold of 4.5 mmol/L had the higher sensitivity (97%) but the specificity was very poor (50%). ¹³This significant difference in sensitivity and specificity may be attributed by characteristics of study population. Mean age of our study population was 26 years, whereas it was 16 years and only included adolescent women in that study. Maternal age has significant impact on overall prevalence of GDM as well as the FPG during pregnancy, Study reported that the addition of maternal age to FPG increase the sensitivity of FPG for diagnosis of GDM. ¹⁴Our study also reported significant positive correlation of maternal age with fasting plasma glucose.

Osman Şevketet. al reported the higher sensitivity (93.4%) of FPG cut-off value of ≤4.5 mmol/l with almost similar specificity (67.6%) like our study.¹⁵ A study from South Africa reported very high sensitivity and specificity (98% and 80% respectively) with the same FPG cut off value,¹⁰ this may be due to gestational age of the study population, they included only the pregnant women with gestation age 24-28 weeks whereas our study population were from all three trimesters. Even though, subgroup analysis with pregnant women of 24-28weeks of gestation in our study population, revealed relatively lower sensitivity and specificity. Ethnicity may also contribute to the sensitivity which needs to be explored by multinational study including the population of different ethnicity.

Since 2000, the UAE has been using two thresholds for “rule-in and rule-out” of GDM based on multiple studies which significantly reduce the number of OGTT. They used FPG cut-off of 5.0mmol/L for “rules-in” GDM with 100% specificity and another cut-off of 4.4mmol/L for “rules-out” GDM with variable sensitivity. Using this approach successfully avoided up to 70% OGTT during pregnancy. Similar results were observed from studies in China and Brazil also.

¹⁸Our study also observed similar result; using FPG with a threshold of 4.5mmol/L could potentially identify about 70% pregnant women with GDM and reduce the need for oral glucose load in a significant number of patients.

Conclusion

FPG may be used as a screening test for selecting the ideal patient for OGTT.Using a protocol adapted in the UAE and China may be a suitable alternative and cost effective strategy for universal screening of GDM.

Declaration